» Articles » PMID: 26593137

Identifying Novel Biomarkers in Sarcoidosis Using Genome-Based Approaches

Overview
Journal Clin Chest Med
Specialty Pulmonary Medicine
Date 2015 Nov 24
PMID 26593137
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

This article briefly reviews conventional biomarkers used clinically to (1) support a diagnosis and (2) monitor disease progression in patients with sarcoidosis. Potential new biomarkers identified by genome-wide screening and the approaches to discover these biomarkers are described.

Citing Articles

Rheumatic Manifestations of Sarcoidosis.

Day J, Hamann P Diagnostics (Basel). 2025; 14(24.

PMID: 39767202 PMC: 11675675. DOI: 10.3390/diagnostics14242842.


Emerging Biomarkers in Cardiac Sarcoidosis and Other Inflammatory Cardiomyopathies.

Roumi J, Taimeh Z Curr Heart Fail Rep. 2024; 21(6):570-579.

PMID: 39365404 PMC: 11511729. DOI: 10.1007/s11897-024-00683-9.


Examination of eQTL Polymorphisms Associated with Increased Risk of Progressive Complicated Sarcoidosis in European and African Descent Subjects.

Casanova N, Camp S, Gonzalez-Garay M, Batai K, Garman L, Montgomery C Eur J Respir Med. 2024; 5(1):359-371.

PMID: 38390497 PMC: 10883688.


Biomarkers and molecular endotypes of sarcoidosis: lessons from omics and non-omics studies.

Ji H, Xi N, Mohan C, Yan X, Jain K, Zang Q Front Immunol. 2024; 14:1342429.

PMID: 38250062 PMC: 10797773. DOI: 10.3389/fimmu.2023.1342429.


Risk Indicators of Sarcoidosis Evolution-Unified Protocol (RISE-UP): protocol for a multi-centre, longitudinal, observational study to identify clinical features that are predictive of sarcoidosis progression.

Drake W, Hsia C, Samavati L, Yu M, Cardenas J, Gianella F BMJ Open. 2023; 13(4):e071607.

PMID: 37012011 PMC: 10083794. DOI: 10.1136/bmjopen-2023-071607.


References
1.
Nunes H, Bouvry D, Soler P, Valeyre D . Sarcoidosis. Orphanet J Rare Dis. 2007; 2:46. PMC: 2169207. DOI: 10.1186/1750-1172-2-46. View

2.
Mrazek F, Stahelova A, Kriegova E, Fillerova R, Zurkova M, Kolek V . Functional variant ANXA11 R230C: true marker of protection and candidate disease modifier in sarcoidosis. Genes Immun. 2011; 12(6):490-4. DOI: 10.1038/gene.2011.27. View

3.
Salazar A, Pinto X, Mana J . Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders. Eur J Clin Invest. 2002; 31(12):1070-7. DOI: 10.1046/j.1365-2362.2001.00913.x. View

4.
Baudin B . [Angiotensin I-converting enzyme (ACE) for sarcoidosis diagnosis]. Pathol Biol (Paris). 2005; 53(3):183-8. DOI: 10.1016/j.patbio.2004.09.003. View

5.
Maliarik M, Chen K, Sheffer R, Rybicki B, Major M, Popovich Jr J . The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am J Respir Cell Mol Biol. 2000; 22(6):672-5. DOI: 10.1165/ajrcmb.22.6.3745. View